William Farrer, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 240 Williamson St Ste 401, Elizabeth, NJ 07202 Phone: 908-282-0500 Fax: 908-282-1482 |
Dr. Syed Jaffry, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 240 Williamson St, Suite 305, Elizabeth, NJ 07202 Phone: 908-353-6608 Fax: 732-603-0624 |
Clark Sherer, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 225 Williamson St, Elizabeth, NJ 07202 Phone: 908-325-6322 Fax: 908-325-6343 |
News Archive
The Community Living Assistance Services and Supports Act - a largely overlooked component of the 2010 Patient Protection and Affordable Care Act - has the potential to transform long-term care financing in the United States from a welfare-based to an insurance-based system, according to the latest issue of Public Policy & Aging Report.
Antares Pharma, Inc. today announced that it has received a Notice of Allowance from the U.S. Patent Office for application 13/584,317. This application, along with U.S. Patent 8,251,947 granted in August of 2012, relate to Antares' injector technology for wet-dry injectable drugs such as lyophilized biologicals or peptide drugs that require dry storage to assure stability.
One of the most controversial topics in neurology today is the prevalence of serious permanent brain damage after traumatic brain injury. Long-term studies and a search for genetic risk factors are required in order to predict an individual's risk for serious permanent brain damage, according to a review article published by Sam Gandy, MD, PhD, from the Icahn School of Medicine at Mount Sinai in a special issue of Nature Reviews Neurology dedicated to TBI.
Supporters of the nation's health law condemn them. A few states, including California and New York, have banned them. Other states limit them.
Even though some combinations of gender, race and/or marital status can factor into the overall survival of nonoperative non-small cell lung cancer patients, gender is the most significant factor impacting overall survival, according to a study presented at the 2008 Chicago Multidisciplinary Symposium in Thoracic Oncology, sponsored by ASTRO, ASCO, IASLC and the University of Chicago.
› Verified 5 days ago